<p><strong>Champions Oncology</strong> (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Monday, 2025-12-15. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Champions Oncology will report an <strong>earnings per share</strong> (EPS) of $0.01. </p>
<p>Champions Oncology bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings Track Record</h3>
<p>During the last quarter, the company reported an EPS beat by $0.03, leading to a 16.02% drop in the share price on the subsequent day.</p>
<p>Here's a look at Champions Oncology's past performance and the resulting price change:</p>
<p></p><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q1 2026</strong></th>
<th align="right"><strong>Q4 2025</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">-0.01</td>
<td align="right">-0.20</td>
<td align="right">0.30</td>
<td align="right">0.01</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">0.02</td>
<td align="right">-0.07</td>
<td align="right">0.36</td>
<td align="right">0.05</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">-16.00</td>
<td align="right">-14.00</td>
<td align="right">-2.00</td>
<td align="right">-12.00</td>
</tr>
</tbody>
</table><p></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765548057_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765548057_0.png"/></p>

<h3>Stock Performance</h3>
<p>Shares of Champions Oncology were trading at $6.3 as of December 10. Over the last 52-week period, shares are up 0.8%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p>To track all earnings releases for Champions Oncology visit their earnings calendar on our site.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>

CSBR

<p>Champions Oncology (NASDAQ:CSBR) will release its quarterly earnings report on December 15, 2025. Analysts estimate an EPS of $0.01. Investors are looking for an earnings beat and positive guidance for the next quarter. Last quarter, the company beat EPS estimates by $0.03 but saw a 16.02% drop in share price. Shares are currently trading at $6.3, up 0.8% over the past year.</p>

Insights Ahead: Champions Oncology's Quarterly Earnings